Systematic review and meta-analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Systematic review and meta-analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index

Published:2017-10-09 Issue:1 Volume:47 Page:6-15
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Lo B.¹^ORCID,Prosberg M. V.¹,Gluud L. L.¹,Chan W.²³^ORCID,Leong R. W.³,van der List E.³,van der Have M.⁴,Sarter H.⁵,Gower-Rousseau C.⁵^ORCID,Peyrin-Biroulet L.⁶^ORCID,Vind I.¹,Burisch J.¹^ORCID

Affiliation:

1. Gastrounit; Medical Division; Copenhagen University Hospital Hvidovre; Hvidovre Denmark

2. Department of Gastroenterology and Hepatology; Singapore General Hospital; Singapore

3. Gastroenterology and Liver Services; Concord Hospital; Sydney Australia

4. Department of Gastroenterology and Hepatology; University Medical Center Utrecht; The Netherlands

5. Public Health Unit; Epimad Registry; Lille University Hospital; Lille France

6. Inserm U954 and Department of Gastroenterology; University Hospital Nancy and Lorraine University; Vandoeuvre-lès-Nancy France

Funder

Københavns Universitet

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14373/fullpdf

Reference35 articles.

1. 3rd European evidence-based consensus on the diagnosis and management of crohn's disease 2016: Part 1: diagnosis and medical management;Gomollón;J Crohn's Colitis,2017

2. Inflammatory bowel disease: cause and immunobiology;Baumgart;Lancet,2007

3. Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease;Williet;Clin Gastroenterol Hepatol,2014

4. Converging goals of treatment of inflammatory bowel disease from clinical trials and practice;Levesque;Gastroenterology,2015

5. Development and validation of a patient-reported disability measurement tool for patients with inflammatory bowel disease;Allen;Aliment Pharmacol Ther,2013

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The “BE-FIT-IBD” study;World Journal of Gastroenterology;2023-11-07

2. Novel symptom clusters predict disease impact and healthcare utilisation in inflammatory bowel disease: Prospective longitudinal follow‐up study;Alimentary Pharmacology & Therapeutics;2023-10-04

3. Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases;Journal of Crohn's and Colitis;2023-09-26

4. The Inflammatory Bowel Disease—Disk Tool for Assessing Disability in Inflammatory Bowel Disease Patients: Validation of the Greek Version;Journal of Clinical Medicine;2023-04-21

5. Multi-item Measures for Paediatric Inflammatory Bowel Diseases: The ABCs of All Those Acronyms;Journal of Crohn's and Colitis;2023-02-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3